Common Conditions
Top Products
Top Prescriptions
LIVE US SUPPORT
M-F 8am-9pm EST
Sat 9am-5:30pm EST
921 Words. 3 minute 53 second Read.
The landscape of men’s sexual health is undergoing a seismic shift. Again.
As a healthcare provider, you’re likely used to shiny new treatments, interventions, and the like entering the picture. But which of these are actually worth paying attention to and which are going the way of snake oil?
Let’s take a look at four trends that are actually set to redefine men’s sexual health in 2025 and beyond.
AI-powered diagnostic tools aren’t the realm of science fiction any longer. They are increasingly in regular use and offer unprecedented accuracy in identifying and predicting sexual health issues.
For instance, one tool HeHealth has demonstrated impressive accuracy in diagnosing common STIs. Specifically, it achieved accuracy rates of 86% for syphilis, 93% for genital herpes, and 96% for genital warts.
Since these AI-powered algorithms are powered by vast datasets, they will only get better at spotting patterns as they analyze more data. The result is that providers will be able to spot issues far, far earlier and can intervene with the most effective treatment plan.
But the trend that will be making a more direct impact? Wearable devices.
Take the FirmTech Tech Ring for instance. This tool is equipped with built-in sensors that track everything from nocturnal erections (a key indicator of cardiovascular health) to erection duration and firmness. It even records ejaculation events. All this data is seamlessly synced to a companion app, providing a huge amount of actionable information for both patients and providers.
The implications are wide-ranging. We’re no longer relying solely on patient self-reporting or sporadic office visits. We now have access to real-time, objective data on patients’ sexual function.
This level of insight was unimaginable just a few years ago.
Testosterone therapy is obviously far from new, but the way it’s being approached certainly is.
Gone are the days of one-size-fits-all treatments of “got Low-T? Here is some extra testosterone.” We’re now entering an era of personalized TRT tailored to each patient’s unique genetic makeup and metabolic profile. New York City med spas, for example, are using genetic profiling to predict individual responses to testosterone replacement therapies.
Novel delivery methods are also changing the game. Long-acting injectable formulations like testosterone undecanoate offer patients the convenience of treatments every 10-12 weeks instead of weekly or biweekly injections. A study published in the Journal of Clinical Endocrinology & Metabolism found this method to be well tolerated by patients and equally effective as more frequent doses in maintaining stable T levels.
But it’s not just about convenience. New oral formulations that bypass first-pass metabolism are hitting the market, providing an effective alternative for patients who prefer to avoid injections.
Combination therapies are also gaining traction. By combining testosterone with agents like hCG or clomiphene citrate, treatments like this are geared to maintain fertility in younger patients which brings us to our next point.
There is indeed a trend of men delaying fatherhood in many developed countries. This is driven by various factors, including longer life expectancy, changing social norms, increased focus on education and career development, and economic considerations.
Fertility preservation, as a result, has become all the more vital when considering treatment for diseases and disorders such as cancer or low testosterone.
There are several new or improved treatment options for preserving fertility.
Breakthroughs in cryopreservation techniques are allowing us to store sperm more effectively and for longer periods. This is particularly vital for patients facing fertility-threatening treatments like chemotherapy or radiation.
Similar to improvements in personalized TRT treatments, genetic advances are also reshaping the landscape of fertility preservation. Improved genetic testing for inherited fertility issues is allowing providers to identify and address potential problems before they impact family planning.
Sildenafil (brand name Viagra) and other PDE5 inhibitors may have revolutionized ED treatment in the 90s, but we’re now on the cusp of the next big leap.
Next-generation PDE5 inhibitors are getting approved and hitting the market. These new drugs offer faster onset of action and longer duration. But the real excitement lies in novel drug classes like soluble guanylate cyclase stimulators, which promise to be effective even in patients who don’t respond to traditional PDE5 inhibitors.
However, the most groundbreaking advancements are happening outside the realm of pharmacology.
Low-intensity shockwave therapy (Li-ESWT) is emerging as a promising non-invasive treatment for ED. By promoting angiogenesis and nerve regeneration, Li-ESWT offers the potential to restore natural erectile function rather than just treat the negative symptoms of ED which is a huge paradigm shift in ED treatment.
Stem cell therapy also continues to make great strides. While still in its experimental stages, early results are promising. The potential to regenerate damaged erectile tissue could completely change the approach to treating ED, especially for post-prostatectomy patients.
For tougher cases that don’t respond to monotherapy, innovative combination approaches are showing promise. Combining PDE5 inhibitors with shockwave therapy or stem cell treatments could offer hope to even the most treatment-resistant patients.
The trends listed here might be labeled the future as of this writing, but it won’t be long before they’re standard treatment options.
This makes staying involved all the more important.
To find the latest news, trends, and expert advice tailored specifically for men’s health and wellness providers, be sure to visit our Provider Corner.